{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,4]],"date-time":"2024-08-04T20:32:30Z","timestamp":1722803550312},"reference-count":15,"publisher":"American Institute of Mathematical Sciences (AIMS)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011]]},"DOI":"10.3934\/mbe.2011.8.861","type":"journal-article","created":{"date-parts":[[2011,6,10]],"date-time":"2011-06-10T18:53:07Z","timestamp":1307731987000},"page":"861-873","source":"Crossref","is-referenced-by-count":6,"title":["Defining candidate drug characteristics for Long-QT (LQT3) syndrome"],"prefix":"10.3934","volume":"8","member":"2321","reference":[{"key":"1","first-page":"4","article-title":"<em>Ionic, molecular, and cellular bases of qt-interval prolongation and torsade de pointes,<\/em>","volume":"4","author":"C. Antzelevitch","year":"2007","journal-title":"Europace"},{"key":"2","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ejps.2008.09.013","article-title":"<em>Multiscale modelling of drug-induced effects on cardiac electrophysiological activity,<\/em>","volume":"36","author":"T. Brennan","year":"2009","journal-title":"European Journal of Pharmaceutical Sciences"},{"key":"3","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/j.1540-8159.2006.00336.x","article-title":"<em>A unique mechanism contributing to initiation of atrial fibrillation,<\/em>","volume":"29","author":"A. Burashnikov","year":"2006","journal-title":"Pacing Clin Electrophysiol"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1038\/23034","article-title":"<em>Linking a genetic defect to its cellular phenotype in a cardiac arrhythmia,<\/em>","volume":"400","author":"C. E. Clancy","year":"1999","journal-title":"Nature"},{"key":"5","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1152\/ajpheart.00312.2006","article-title":"<em>Pharmacogenetics and anti-arrhythmic drug therapy: A theoretical investigation,<\/em>","volume":"292","author":"C. E. Clancy","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"6","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1161\/01.CIR.61.6.1217","article-title":"<em>Test of a model of antiarrhythmic drug action. Effects of quinidine and lidocaine on myocardial conduction,<\/em>","volume":"61","author":"L. Hondeghem","year":"1980","journal-title":"Circulation"},{"key":"7","article-title":"\"Mathematical Physiology,\"","author":"J. Keener","year":"2009","journal-title":"Springer"},{"key":"8","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.1152\/ajpheart.01347.2006","article-title":"<em>Regulation of Ca2+ and electrical alternans in cardiac myocytes: Role of CAMKII and repolarizing currents,<\/em>","volume":"292","author":"L. M. Livshitz","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"9","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/comjnl\/7.4.308","article-title":"<em>A simplex method for function minimization,<\/em>","volume":"7","author":"J. A. Nelder","year":"1965","journal-title":"Computer Journal"},{"key":"10","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/S1359-6446(98)01277-X","article-title":"<em>Biological simulations in drug discovery,<\/em>","volume":"4","author":"Denis Noble","year":"1999","journal-title":"Drug Discovery Today"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eum202","article-title":"<em>Modelling the molecular basis of cardiac repolarization,<\/em>","volume":"9","author":"Y. Rudy","year":"2007","journal-title":"Europace"},{"key":"12","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.mbs.2008.12.001","article-title":"<em>A note on a method for determining advantageous properties of an anti-arrhythmic drug based on a mathematical model of cardiac cells,<\/em>","volume":"217","author":"A. Tveito","year":"2009","journal-title":"Mathematical Biosciences"},{"key":"13","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1152\/ajpheart.00270.2006","article-title":"<em>In silico assessment of Y1795C and Y1795H SCN5A mutations: Implication for inherited arrhythmogenic syndromes,<\/em>","volume":"292","author":"S. Vecchietti","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"14","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1172\/JCI119335","article-title":"<em>Pharmacological targeting of long qt mutant sodium channels<\/em>,","volume":"99","author":"D. W. Wang","year":"1997","journal-title":"Journal of Clinical Investigation"},{"key":"15","article-title":"<em>Genetic mutations and arrhythmia: Simulation from DNA to electrocardiogram<\/em>,","volume":"40","author":"Zheng I. Zhu","year":"2007","journal-title":"Journal of Electrocardiology"}],"container-title":["Mathematical Biosciences and Engineering"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.aimspress.com\/article\/10.3934\/mbe.2011.8.861\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T08:58:24Z","timestamp":1580547504000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.aimspress.com\/article\/10.3934\/mbe.2011.8.861"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.3934\/mbe.2011.8.861","relation":{},"ISSN":["1551-0018"],"issn-type":[{"value":"1551-0018","type":"print"}],"subject":[],"published":{"date-parts":[[2011]]}}}